IP Library › Assignment 071971/0600
Patent Assignment
Reel/Frame 071971/0600

Assignment of Assignor's Interest

Recorded: 2025-08-08 Pages: 18
Assignor
SUMITOMO PHARMA SWITZERLAND GMBH
Executed: 2025-08-06
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Properties (17)
Methods of Treating Uterine Fibroids
Application: 16/370,299 →
Publication: US 2019/0262346
Methods of Treating Endometriosis
Application: 17/317,769 →
Publication: US 2021/0401841
Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids
Application: 17/866,201 →
Publication: US 2022/0370462
Methods of Preventing Pregnancy
Application: 18/427,579 →
Publication: US 2024/0165118
Treatment of Prostate Cancer
Application: 16/369,729 →
Publication: US 2019/0224196
Treatment of Prostate Cancer
Application: 16/563,161 →
Publication: US 2020/0129507
Treatment of Prostate Cancer
Application: 16/998,900 →
Publication: US 2021/0205303
Treatment of Prostate Cancer
Application: 17/866,203 →
Publication: US 2022/0401443
Treatment of Prostate Cancer
Application: 18/758,904 →
Publication: US 2024/0358700
Treatment of Prostate Cancer
Application: 18/937,891 →
Publication: US 2025/0057839
Treatment of Prostate Cancer
Application: 18/959,460 →
Publication: US 2025/0082632
Treatment of Prostate Cancer
Application: 19/264,673 →
Combination Solid Oral Dosage Forms of Gonadotropin-Releasing Hormone Antagonists
Application: 18/070,341 →
Publication: US 2023/0165800
Crystalline Forms of N-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxy-3-Pyridazinyl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl)Phenyl)-N'-Methoxyurea
Application: 17/716,963 →
Publication: US 2022/0396582
Crystalline Forms of N-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxy-3-Pyridazinyl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl)Phenyl)-N'-Methoxyurea
Application: 19/212,513 →
Crystalline Solvated Forms of N-(4-(1-(2,6-Difluorobenzyl)-5- ((Dimethylamino)Methyl)-3-(6-Methoxy-3-Pyridazinyl)-2,4-Dioxo-1,2,3,4- Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl)Phenyl)-N'-Methoxyurea
Application: 17/716,965 →
Publication: US 2022/0372044
Crystalline Solvated Forms of N-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxy-3-Pyridazinyl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl)Phenyl)-N'-Methoxyurea
Application: 18/636,642 →
Publication: US 2025/0066382
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 3, 2019
From: JOHNSON, BRENDAN MARK
To: ROIVANT SCIENCES, INC.
Reel/Frame 048783/0031 →
Assignment of Assignor's Interest Apr 3, 2019
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 048786/0460 →
Assignment of Assignor's Interest Apr 3, 2019
From: MACLEAN, DAVID
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 048786/0391 →
Assignment of Assignor's Interest Apr 3, 2019
From: ROIVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048786/0326 →
Assignment of Assignor's Interest Apr 3, 2019
From: MYOVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048782/0843 →
Assignment of Assignor's Interest Apr 3, 2019
From: SEELY, LYNN; RAJASEKHAR, VIJAYKUMAR REDDY
To: MYOVANT SCIENCES, INC.
Reel/Frame 048782/0772 →
Assignment of Assignor's Interest Apr 3, 2019
From: MYOVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048782/0931 →
Assignment of Assignor's Interest Apr 3, 2019
From: ROIVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048786/0613 →
Assignment of Assignor's Interest Apr 3, 2019
From: MUDD, PAUL N., JR.
To: ROIVANT SCIENCES, INC.
Reel/Frame 048786/0562 →
Assignment of Assignor's Interest Apr 24, 2019
From: SUKHATME, MAYUKH VASANT
To: ROIVANT SCIENCES, INC.
Reel/Frame 048987/0441 →
Assignment of Assignor's Interest Apr 24, 2019
From: JOHNSON, BRENDAN MARK; MUDD, PAUL N., JR.; WOLLOWITZ, SUSAN
To: ROIVANT SCIENCES, INC.
Reel/Frame 048987/0360 →
Assignment of Assignor's Interest Apr 24, 2019
From: ROIVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048987/0418 →
Assignment of Assignor's Interest Apr 24, 2019
From: TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 048987/0261 →
Assignment of Assignor's Interest Apr 24, 2019
From: ROIVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048987/0451 →
Assignment of Assignor's Interest Apr 24, 2019
From: MYOVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 048987/0116 →
Assignment of Assignor's Interest Apr 24, 2019
From: TANIMOTO, MASATAKA
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 048987/0312 →
Assignment of Assignor's Interest Apr 24, 2019
From: HIBBERD, MARK
To: TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
Reel/Frame 048987/0176 →
Assignment of Assignor's Interest Apr 24, 2019
From: SEELY, LYNN; RAJASEKHAR, VIJAYKUMAR REDDY
To: MYOVANT SCIENCE, INC.
Reel/Frame 048987/0027 →
Corrective Assignment to Correct the Name of the Receiving Party on the Cover Sheet from Myovant Science, Inc. to Myovant Sciences, Inc. Previously Recorded on Reel 048987 Frame 0027. Assignor(S) Hereby Confirms the Assignment. May 6, 2019
From: SEELY, LYNN; RAJASEKHAR, VIJAYKUMAR REDDY
To: MYOVANT SCIENCES, INC.
Reel/Frame 049095/0553 →
Assignment of Assignor's Interest Sep 11, 2019
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 050346/0818 →
Assignment of Assignor's Interest Sep 11, 2019
From: JOHNSON, BRENDAN MARK
To: ROIVANT SCIENCES, INC.
Reel/Frame 050346/0650 →
Assignment of Assignor's Interest Sep 11, 2019
From: MUDD, PAUL N., JR.
To: ROIVANT SCIENCES, INC.
Reel/Frame 050346/0848 →
Assignment of Assignor's Interest Sep 11, 2019
From: MACLEAN, DAVID
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 050346/0791 →
Assignment of Assignor's Interest Sep 11, 2019
From: ROIVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 050346/0899 →
Assignment of Assignor's Interest Sep 11, 2019
From: MYOVANT SCIENCES, INC.
To: MYOVANT SCIENCES GMBH
Reel/Frame 050346/0723 →